[HTML][HTML] COVID-19 and myocarditis: a systematic review and overview of current challenges

T Castiello, G Georgiopoulos, G Finocchiaro… - Heart failure …, 2022 - Springer
Myocardial inflammation in COVID-19 has been documented. Its pathogenesis is not fully
elucidated, but the two main theories foresee a direct role of ACE2 receptor and a …

[HTML][HTML] Neutrophil extracellular traps (NETs) in severe SARS-CoV-2 lung disease

M Szturmowicz, U Demkow - International journal of molecular sciences, 2021 - mdpi.com
Neutrophil extracellular traps (NETs), built from mitochondrial or nuclear DNA, proteinases,
and histones, entrap and eliminate pathogens in the course of bacterial or viral infections …

[HTML][HTML] Multidisciplinary approach to brain fog and related persisting symptoms post COVID-19

K Krishnan, YF Lin, KRM Prewitt, DA Potter - Journal of health service …, 2022 - Springer
A third of patients who developed COVID-19 experience a persisting, diverse array of
symptoms including respiratory, neurological, and psychiatric complaints referred to as post …

Inflammatory cytokine: IL-17A signaling pathway in patients present with COVID-19 and current treatment strategy

T Shibabaw - Journal of inflammation research, 2020 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) is a globally communicable public health
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2) …

[HTML][HTML] Is the COVID‐19 thrombotic catastrophe complement‐connected?

EM Conway, ELG Pryzdial - Journal of Thrombosis and Haemostasis, 2020 - Elsevier
In December 2019, the world was introduced to a new betacoronavirus, referred to as
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) for its propensity to cause …

Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID …

DS Al-Hadrawi, HT Al-Rubaye, AF Almulla… - Acta …, 2023 - cambridge.org
Background: Long coronavirus disease 2019 (LC) is a chronic sequel of acute COVID-19.
The exact pathophysiology of the affective, chronic fatigue and physiosomatic symptoms …

[HTML][HTML] Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality

A Leatherdale, S Stukas, V Lei, HE West… - Medical microbiology …, 2022 - Springer
Mechanisms underlying the SARS-CoV-2-triggered hyperacute thrombo-inflammatory
response that causes multi-organ damage in coronavirus disease 2019 (COVID-19) are …

[HTML][HTML] Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection

M Akbarzadeh-Khiavi, M Torabi, L Rahbarnia, A Safary - Infection, 2022 - Springer
Abstract Purpose The Coronavirus disease 2019 (COVID-19) pandemic is one of the most
devastating global problems. Regarding the lack of disease-specific treatments, repurposing …

[HTML][HTML] Vagus nerve stimulation: a potential adjunct therapy for COVID-19

E Azabou, G Bao, R Bounab, N Heming… - Frontiers in …, 2021 - frontiersin.org
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (COVID-19) through excessive end organ inflammation. Despite …

[HTML][HTML] Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical …

SH Hamidi, S Kadamboor Veethil, SH Hamidi - Pharmacological Reports, 2021 - Springer
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
pulmonary injury or multiple-organ injury by various pathological pathways. Transforming …